|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 43/40 | |
| A61K 31/445 | |||
| A61K 31/497 |
| (11) | Number of the document | 2111107 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07869989.9 |
| Date of filing the European patent application | 2007-12-27 | |
| (97) | Date of publication of the European application | 2009-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/088978 |
| Date | 2007-12-27 |
| (87) | Number | WO 2008/083238 |
| Date | 2008-07-10 |
| (30) | Number | Date | Country code |
| 877903 P | 2006-12-28 | US | |
| 964461 | 2007-12-26 | US |
| (72) |
CHEN, Xin, US
CHENG, Peng, CN
CLEMENS, L., Edward, US
JOHNSON, Jeffrey, D., US
MA, Jingyuan, US
MURPHY, Alison, US
NASHASHIBI, Imad, US
RABBAT, Christopher, J., US
SONG, Jiangao, US
WILSON, Maria, E., US
ZHU, Yan, US
ZHAO, Zuchun, US
|
| (73) |
Metabolex Inc.,
3876 Bay Center Place, Hayward, CA 94545,
US
|
| (54) | HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS |
| HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS |